Series date: 
01/01/2026 - 7:30am to 12/31/2026 - 8:30am
COURSE DIRECTOR
David Dingli, M.D., Ph.D.

DESCRIPTION
This BMT weekly meeting is intended for Mayo personnel only. Occasionally, we may invite speakers or other faculty from outside of the BMT program to present at the meeting on matters of mutual educational or practice interest. BMT meeting is multidisciplinary and encompasses both the Adult and Pediatric BMT Groups and is designed to be a forum to enhance the practice, education and research efforts.  

Live-Streamed; Weekly on Wednesday from 7:30-8:30 a.m.

TARGET AUDIENCE
Allied Health Professionals, Healthcare Executives, Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Psychologists, Registered Dietitians, Resident Fellows, Scientist Researcher, PhDs, Social Workers, and Students.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
  • Analyze innovations in bone marrow transplant and cell therapies to maintain the highest standards of patient care, innovation and research.
  • Identify competency and enhance safety in the BMT practice.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


CREDIT STATEMENT(S)
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 

David Dingli, M.D. - Honoraria - 21GRAMS; Advarra; Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Argenx US Inc; AstraZeneca Pharmaceuticals LP; BMS Global, Inc., Curio Science LLC; DAVA Oncology, LP; Engage Health Media; Janssen Biotech, Inc., Janssen Scientific Affairs, LLC; Legend Biotech, Inc; Merck Sharp & Dohme Corp.; Novartis; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc.; Remedy Health Media

All relevant financial relationships have been mitigated. 
 
No relevant financial relationship(s) with ineligible companies:
Hassan Alkhateeb, M.D.
Mikayla Baumgartner (Coordinator)
Kassy McCarty (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
 
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
 
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

QUESTIONS?
Contact Mikayla Baumgartner or Kassy McCarty
Where did the idea for the course originate?: 
Minnesota

Sessions

Session Date
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services TP53 mutant VEXAS sample post transplant Extended Stay BMT Inpatients 07/29/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services 8 5 2026 08/05/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services 08/12/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services journal Club Donor selection and human leukocyte antigen loss leukemia relapse after hematopoietic cell transplantation 08/19/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Auto Handoff Patient Selection Conference 08/26/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Epic Tips and Tricks Patient Selection Conference Cell Doses in Storage for BMT Patients 09/02/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Extended Stay BMT Inpatients Request for BMT Biobank samples Pre ASCT in patients with PTCL to test for ctDNA by Natera 09/09/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Journal Club Nonmyeloablative conditioning combined with the anti CD117 antibody briquilimab in older adults with high risk AML and MDS 09/16/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Extended Stay BMT Inpatients Signing subsequent cycles of maintenance chemotherapy GVHD treatment plans by BMT APP 09/23/2026 - 7:30am to 8:30am
Bone Marrow Transplant Weekly Meeting 2026 Inpatient Outpatient Services Patient Selection Conference Changes in the BMT fellow rotation BMT Interview Dr Tirumebet Minayehu 09/30/2026 - 7:30am to 8:30am

Pages